Sleep Medicine
Jazz Pharmaceuticals PLC focuses on clinical research in narcolepsy, with attention to the management of symptoms and related patient outcomes in sleep disorders.
- Narcolepsy
- Sleep-wake regulation
- Excessive daytime sleepiness
Its research activity in this area reflects interest in therapies used to support individuals living with chronic hypersomnolence and disrupted sleep patterns.
Cardiovascular Monitoring
The sponsor also examines blood pressure outcomes in people with narcolepsy, indicating therapeutic interest in the cardiovascular effects associated with treatment use.
- Systolic blood pressure
- Ambulatory blood pressure assessment
- Cardiovascular safety
This area links sleep-medicine treatment with monitoring of hypertension-related parameters and broader cardiometabolic considerations.
Oxybate-Based Therapy
Clinical interest extends to oxybate treatment for narcolepsy, including transition from high-sodium oxybate to XYWAV in the context of long-term symptom management.
- Oxybate formulations
- Sodium reduction
- Treatment switching
The therapeutic focus includes formulations designed for patients who require ongoing management of cataplexy and other narcolepsy-related manifestations.
